Physician profile
Christopher Scott Witt
NPI 1194089383
$3,775.87
in general payments reported to CMS, 2019-2025
46 companies · $819 in 2025
The $819 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $402 · 2020: $393 · 2021: $647 · 2022: $448 · 2023: $550 · 2024: $517 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,886.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $454.90 | 2022-2025 | Nuzyra |
| Stryker Corporation | $393.51 | 2019-2025 | Ortholoc 3di Crosscheck, Graftjacket, Citrefix |
| Depuy Synthes Sales INC. | $337.70 | 2021-2025 | Motoband, Minibunion |
| Horizon Therapeutics Plc | $326.77 | 2019-2022 | |
| Smith+Nephew, INC. | $258.50 | 2019-2025 | Collagenase Santyl, Bone Anchors With Arthroscopic Delivery System, Coblation |
| Alfasigma USA, INC. | $161.08 | 2020-2022 | |
| Orthofix Medical, INC. | $151.10 | 2019-2025 | Physio-Stim |
| Abbott Laboratories | $109.18 | 2019-2023 | Proclaim |
| Abbvie INC. | $108.23 | 2021 | |
| Pylant Medical | $103.33 | 2023-2025 | |
| Melinta Therapeutics, LLC | $100.91 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $100.03 | 2021-2022 | |
| Nevro Corp. | $96.05 | 2023-2024 | Senza |
| Amgen INC. | $87.93 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $85.57 | 2021-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $58.59 | 2021-2023 | |
| Avita Medical Americas, LLC | $58.15 | 2025 | Permeaderm, Recell, Cohealyx |
| Next Science LLC | $57.23 | 2025 | Xperience, Blastx |
| Integra Lifesciences Corporation | $56.32 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $52.43 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Reprise Biomedical, INC. | $45.76 | 2023 | Miro3d |
| Treace Medical Concepts, INC. | $42.94 | 2025 | |
| Tactile Systems Technology INC | $39.62 | 2023 | Entre Plus, Flexitouch Plus |
| Cashflow Solutions, LLC | $37.84 | 2024-2025 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Arteriocyte Medical Systems, INC. | $30.03 | 2019 | |
| Nalu Medical, INC. | $29.38 | 2025 | Nalu Neurostimulation System |
| Cardiovascular Systems INC. | $27.13 | 2019 | |
| Wright Medical Technology, INC. | $25.47 | 2019 | |
| Novum Pharma, LLC | $23.61 | 2019 | |
| Arthrosurface Incorporated | $22.87 | 2020 | |
| Axogen | $22.64 | 2025 | |
| Acell, INC. | $22.35 | 2020 | |
| Merck Sharp & Dohme LLC | $21.89 | 2019 | |
| Stability Biologics, LLC | $21.80 | 2023 | |
| Biotissue Holdings INC. | $20.14 | 2021 | |
| Avanos Medical | $19.77 | 2024 | On-Q* Pump and Accessories |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.38 | 2020 | |
| Medtronic Vascular, INC. | $18.25 | 2020 | |
| Cpm Medical Consultants, LLC | $18.13 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $17.57 | 2022 | |
| Sebela Pharmaceuticals INC. | $17.03 | 2019 | |
| Flower Orthopedics Coporation | $16.79 | 2022 | |
| Medtronic, INC. | $16.29 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.64 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $14.46 | 2019 | |
| Osiris Therapeutics INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Witt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.